Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges
Audiology Research · 04.12.2023 · 13 (6) · 952-966
DOI: 10.3390/audiolres13060083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Audiology Research, online erschienen am 04.12.2023. Verfasst von Roni Hahn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801,…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, United States-Israel Binational Science Foundation, Israel Science Foundation within the Israel Precision Medicine Partnership Program.
Abstract (Originalsprache)
Hearing loss stands as the most prevalent sensory deficit among humans, posing a significant global health challenge. Projections indicate that by 2050, approximately 10% of the world’s population will grapple with disabling hearing impairment. While approximately half of congenital hearing loss cases have a genetic etiology, traditional interventions such as hearing aids and cochlear implants do not completely restore normal hearing. The absence of biological treatment has prompted significant efforts in recent years, with a strong focus on gene therapy to address hereditary hearing loss. Although several studies have exhibited promising recovery from common forms of genetic deafness in mouse models, existing challenges must be overcome to make gene therapy applicable in the near future. Herein, we summarize the primary gene therapy strategies employed over past years, provide an overview of the recent achievements in preclinical studies for genetic hearing loss, and outline the current key obstacles to cochlear gene therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
Förderung
- Israel Science Foundation
- United States-Israel Binational Science Foundation
- Israel Science Foundation within the Israel Precision Medicine Partnership Program
Zitieren
APA
Hahn, R., & Avraham, K. B. (2023). Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges. Audiology Research, 13(6), 952-966. https://doi.org/10.3390/audiolres13060083
Vancouver
Hahn R, Avraham KB. Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges. Audiology Research. 2023;13(6):952-966. doi:10.3390/audiolres13060083
BibTeX
@article{Hahn2023,
author = {Hahn, Roni and Avraham, Karen B},
title = {Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges},
journal = {Audiology Research},
year = {2023},
volume = {13},
number = {6},
pages = {952--966},
doi = {10.3390/audiolres13060083}
}
EUVIMED